Baseline Ex Vivo and Molecular Responses of Plasmodium falciparum Isolates to Piperaquine before Implementation of Dihydroartemisinin-Piperaquine in Senegal

Dihydroartemisinin-piperaquine, which was registered in 2017 in Senegal, is not currently used as the first-line treatment against uncomplicated malaria. A total of 6.6% to 17.1% of P. falciparum isolates collected in Dakar in 2013 to 2015 showed ex vivo-reduced susceptibility to piperaquine. Neithe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Robert, Marie Gladys, Foguim Tsombeng, Francis, Gendrot, Mathieu, Diawara, Silman, Madamet, Marylin, Kounta, Mame Bou, Wade, Khalifa Ababacar, Fall, Mansour, Gueye, Mamadou Wague, Benoit, Nicolas, Nakoulima, Aminata, Bercion, Raymond, Amalvict, Rémy, Fall, Bécaye, Wade, Boubacar, Diatta, Bakary, Pradines, Bruno
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2019
Assuntos:
Epidemiology and Surveillance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496083/
https://ncbi.nlm.nih.gov/pubmed/30782997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02445-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados